Autor:	FISCHER, LINDSAY
Předmět:	T cells MEDICAL quality control NON-Hodgkin's lymphoma IMMUNOGLOBULINS ANTINEOPLASTIC agents CYTOKINE release syndrome IMMUNOTHERAPY RITUXIMAB PREDNISONE CELLULAR therapy ONCOLOGY nursing VINCRISTINE PROGRESSION-free survival B cell lymphoma
Zdroj:	Oncology Nursing News; Feb2024, Vol. 18 Issue 1, p12-14, 3p
Abstrakt:	The article discusses the results of a meta-analysis which showed that intensive chemotherapy followed by autologous stem cell transplant (ASCT) results in a two-year progression-free survival rate of 54 percent. Topics include limitations to ASCT, standard of care for diffuse large B-cell lymphoma, and an instance shared by Dr. Laura J. Zitella in which a bispecific antibody helped her patient achieved better quality of life.
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu